Rigel Pharmaceuticals Inc banner

Rigel Pharmaceuticals Inc
NASDAQ:RIGL

Watchlist Manager
Rigel Pharmaceuticals Inc Logo
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Watchlist
Price: 27.04 USD 5.13% Market Closed
Market Cap: $490.8m

Intrinsic Value

The intrinsic value for Rigel Pharmaceuticals Inc (RIGL) under the Base Case is 45.14 USD. Compared with the current market price of 27.04 USD, the stock appears Undervalued by 40%.

Based on two methods:

Both DCF and multiples point to undervaluation.

RIGL Intrinsic Value
45.14 USD
Undervaluation 40%
Intrinsic Value
Price $27.04
Worst Case
Base Case
Best Case
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value $36.11
Get notified when the price drops into your buy zone
Intrinsic Value $45.14
Margin of Safety 20% $36.11
Current Price $27.04
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about RIGL?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is RIGL valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Rigel Pharmaceuticals Inc.

Explain Valuation
Alternatives to RIGL

Wall St
Price Targets

Dividends

Rigel Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

RIGL Insider Trading
Buy and sell transactions by insiders

RIGL News

What is the Intrinsic Value of one RIGL stock?

The intrinsic value for Rigel Pharmaceuticals Inc (RIGL) under the Base Case is 45.14 USD.

Is RIGL stock undervalued or overvalued?

Compared with the current market price of 27.04 USD, the stock appears Undervalued by 40%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett